Home » FDA Collaborates to Work Against Rare Cataract Condition
FDA Collaborates to Work Against Rare Cataract Condition
Toxic Anterior Segment Syndrome is a rare condition that can occur after cataract surgery. The U.S. Food and Drug Administration in collaboration with other government agencies, unveiled a program to monitor medical devices used in cataract surgery in an effort to stem outbreaks of the rare, inflammatory condition.
Medical News Today
Medical News Today
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May